Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Critical Care (London, England)
|
February 25, 2021
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak
Andrea Coppadoro, Annalisa Benini, Robert Fruscio, et al.
Journal of Hepatology
|
June 12, 2020
High rates of 30-day mortality in patients with cirrhosis and COVID-19
Massimo Iavarone, Roberta D'Ambrosio, Alessandro Soria, et al.
Plos One
|
July 19, 2012
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience
Amedeo Capetti, Simona Landonio, Paola Meraviglia, et al.
International Journal of Antimicrobial Agents
|
December 10, 2013
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study
Amedeo Capetti, Paola Meraviglia, Simona Landonio, et al.
Journal of Viral Hepatitis
|
December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting
Massimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
Journal of Clinical Medicine
|
October 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration
Valerio Rosato, Riccardo Nevola, Marcello Dallio, et al.
World Journal of Gastroenterology
|
January 2, 2026
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort
Barbara Coco, Maria Giovanna Quaranta, Maria Elena Tosti, et al.
Plos One
|
November 19, 2013
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial
Stefano Rusconi, Paola Vitiello, Fulvio Adorni, et al.
Plos One
|
March 1, 2017
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
Loreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Plos One
|
January 3, 2018
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
Loreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Critical Care (London, England)
|
February 25, 2021
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak
Andrea Coppadoro, Annalisa Benini, Robert Fruscio, et al.
Journal of Hepatology
|
June 12, 2020
High rates of 30-day mortality in patients with cirrhosis and COVID-19
Massimo Iavarone, Roberta D'Ambrosio, Alessandro Soria, et al.
Plos One
|
July 19, 2012
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience
Amedeo Capetti, Simona Landonio, Paola Meraviglia, et al.
International Journal of Antimicrobial Agents
|
December 10, 2013
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study
Amedeo Capetti, Paola Meraviglia, Simona Landonio, et al.
Journal of Viral Hepatitis
|
December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting
Massimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
Journal of Clinical Medicine
|
October 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration
Valerio Rosato, Riccardo Nevola, Marcello Dallio, et al.
World Journal of Gastroenterology
|
January 2, 2026
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort
Barbara Coco, Maria Giovanna Quaranta, Maria Elena Tosti, et al.
Plos One
|
November 19, 2013
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial
Stefano Rusconi, Paola Vitiello, Fulvio Adorni, et al.
Plos One
|
March 1, 2017
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
Loreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Plos One
|
January 3, 2018
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
Loreta A Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi, et al.
Page
of 6